Synapse - Pharmacokinetics and toxicities after Evomela® (propylene glycol free melphalan) with hematopoietic stem cell transplant (HCT) for multiple myeloma (MM), AL amyloidosis (AL), lymphoma, acute myeloid leukemia (AML), and myelodysplastic syndrome (MDS)

Pharmacokinetics and toxicities after Evomela® (propylene glycol free melphalan) with hematopoietic stem cell transplant (HCT) for multiple myeloma (MM), AL amyloidosis (AL), lymphoma, acute myeloid leukemia (AML), and myelodysplastic syndrome (MDS) Meeting Abstract

Authors:	Shah, G. L.; Landau, H.; Sarubbi, C.; Schofield, R.; Lin, A.; Bhatt, V.; Harnicar, S.; Devlin, S. M.; Castro-Malaspina, H.; Chung, D. J.; Dahi, P. B.; Gyurkocza, B.; Koehne, G.; Matasar, M. J.; Moskowitz, C. H.; Papadopoulos, E. B.; Sauter, C. S.; Shaffer, B. C.; Tamari, R.; Carlow, D.; Giralt, S. A.
Abstract Title:	Pharmacokinetics and toxicities after Evomela® (propylene glycol free melphalan) with hematopoietic stem cell transplant (HCT) for multiple myeloma (MM), AL amyloidosis (AL), lymphoma, acute myeloid leukemia (AML), and myelodysplastic syndrome (MDS)
Meeting Title:	2018 BMT Tandem Meetings
Journal Title:	Biology of Blood and Marrow Transplantation
Volume:	24
Issue:	3 Suppl. 1
Meeting Dates:	2018 Feb 21-25
Meeting Location:	Salt Lake City, UT
ISSN:	1083-8791
Publisher:	Elsevier Inc.
Date Published:	2018-03-01
Start Page:	S79
End Page:	S80
Language:	English
ACCESSION:	WOS:000425476000085
PROVIDER:	wos
DOI:	10.1016/j.bbmt.2017.12.664
Notes:	Meeting Abstract: 81 -- Meeting date is incorrect in the original publication's table of contents -- Source: Wos